Antidepressant Suicide Data To Be Evaluated For FDA By Columbia University
Executive Summary
Columbia University will coordinate a review of pediatric antidepressant suicidal event data for FDA
You may also be interested in...
As FDA Suicidality Reviews Become More Common, Firms Move Into C-CASA
FDA's review of anticonvulsant drugs for suicidality risks suggests that firms should reevaluate their clinical development strategies to anticipate a growing need for such data
As FDA Suicidality Reviews Become More Common, Firms Move Into C-CASA
FDA's review of anticonvulsant drugs for suicidality risks suggests that firms should reevaluate their clinical development strategies to anticipate a growing need for such data
Antidepressant Fallout Includes Change In FDA Pediatric Study Procedure
Studies conducted under the Best Pharmaceuticals for Children Act will be included in labeling, FDA Office of Medical Policy Director Robert Temple, MD, told the House Energy & Commerce/Oversight Subcommittee Sept. 23